Binaytara Launches $25,000 Implementation Science Research Grants to Accelerate Real-World Cancer Care Innovation

Binaytara has launched $25,000 Implementation Science Research Grants to accelerate innovation in real-world cancer care and reduce disparities in outcomes. Open to hematology/oncology fellows and early-career investigators presenting at the Summit on Cancer Health Disparities 2026 (SCHD26), these grants empower the next generation of researchers to design scalable, practice-changing solutions that promote equitable cancer care delivery.

The new grants aim to accelerate innovative research addressing inequities in cancer care and outcomes.

BELLEVUE, WA— Binaytara is excited to announce competitive Implementation Science Research Grants of $25,000 each to support innovative projects that will make a real difference in how we deliver cancer care and improve patient outcomes. This grant is eligible only to current hematology/oncology fellows or early-career researchers who have an abstract accepted for presentation at the Summit on Cancer Health Disparities 2026, Binaytara’s flagship continuing medical education conference.

These grants support the development of bold, practice-changing research that reduces cancer disparities. Hematologist/Oncology fellows and early-career professionals will not only have the chance to spotlight their research in this live competition at SCHD26, but also hone their communication skills in the process.

The Impact Pitch: A New Way to Fund Innovative Cancer Research

The winners will be selected through our Impact Pitch, a Shark Tank–style competition that will redefine how we fund innovative cancer research. Reviewers will evaluate each proposal, and the audience will vote to select the winning projects that receive Binaytara Implementation Science Research Grants. This is not a traditional grant application process. It is engaging, it is competitive, and it puts early-career cancer researchers in the spotlight to showcase their most innovative research ideas for improving cancer care and delivery.

The competition invites visionary early-career investigators who are ready to challenge conventional thinking and design practical, scalable solutions for cancer care delivery.

If that sounds like you, we cannot wait to see you on the SCHD26 stage. This initiative is part of Binaytara’s broader mission to minimize cancer disparities and aligns with our upcoming flagship continuing medical education conference, the Summit on Cancer Health Disparities (SCHD).

SCHD26: Uniting Oncology Leaders to Tackle Cancer Disparities

SCHD is a leading national oncology conference dedicated to advancing health equity in cancer care. Held on March 27-28, 2026, in Bellevue, Washington, this CME/CE/ACPE-accredited cancer conference brings together oncologists and healthcare providers from diverse clinical settings to address persistent cancer disparities affecting the underserved population. Dr. David Aboulafia (Virginia Mason Medical Center) and Dr. Ana Maria Lopez (Sidney Kimmel Cancer Center), recognized leaders in oncology and cancer health disparities research, are set to chair SCHD26, bringing a wealth of expertise and innovative vision to the conference.

Funding Practical, Scalable Strategies for Health Equity

True equity remains one of the most critical yet under addressed challenges in oncology today. While we celebrate breakthroughs in treatment and technology, we must ask harder questions: Can patients in underserved areas actually access these innovations? Do clinicians in rural settings know about emerging therapies that could save lives? What human cost do we pay when translating research from laboratory to clinic takes too long? How does the crushing financial weight of cancer treatment affect survival itself? Could better awareness and prevention strategies reduce mortality rates?

These questions and more will be highlighted at SCHD26. Anchoring these critical conversations, The Binaytara Research Challenge will cut through complexity with clear, action-oriented proposals designed to dismantle barriers in cancer care. Understanding the convergence of factors that shape cancer patient outcomes is essential. SCHD26 aims to tackle these pressing issues and inspire attendees to adopt strategies that actively work to eliminate cancer disparities.

Leaders Share Why Implementation Science Funding Matters

“Binaytara is at the forefront of examining and addressing disparities in cancer care across the globe,” said Dr. Martha Pritchett Mims, professor of hematology & oncology at Baylor College of Medicine, and co-chair of the SCHD26 Abstract Committee for Binaytara. “These implementation science grants are the next step in supporting these efforts and represent a real commitment to moving the needle in cancer care.”

“To address disparities in cancer care, effective programs must build on successful implementation,” said Dr. Don S. Dizon, Service Line Chief of Hematology and Oncology and the Jane F. Desforges, M.D., Chair in Hematology and Oncology at Tufts University School of Medicine, and co-chair of the SCHD26 Abstract Committee for Binaytara. “This requires intentional, evidence-based efforts in strategic planning and analysis. However, funding for these early efforts is often lacking. Binaytara aims to address this need by encouraging early-career scientists to explore and develop in this field. By providing resources and support, the foundation hopes to foster innovation and progress in cancer care, ultimately leading to more equitable treatment outcomes for patients.”

"Binaytara is focused on achieving equitable cancer care for all, including the most marginalized populations,” said Dr. David Aboulafia, a clinical professor of medicine at the University of Washington and attending hematologist at Virginia Mason, Chair of the Binaytara Board of Directors, and Co-Chair of SCHD26. “We are fostering the next generation of leaders by offering competitive Implementation Science Research Grants, each for $25,000, to support novel projects that advance equitable cancer care delivery and outcomes. This is a wonderful opportunity to help launch the next phase of your career."

“The Impact Pitch is a fast-paced, high-energy, and inspiring way to celebrate and invest in the next generation of innovators transforming cancer care,” says Dr. Binay Shah, co-founder and president of Binaytara. “The Impact Pitch is where science meets showtime because it gives researchers a chance to present their research project live on stage to an audience who will be voting for the grant winners.”

Join the SCHD26 Stage and Make Your Impact

Start by submitting your abstract to the Summit on Cancer Health Disparities 2026. The deadline for abstract submission is December 15, 2025. For more information on grant proposal guidelines and abstract submission, visit the Binaytara Research Grants page.